Created with Sketch.
Advances in Women's Health
15 minutes | Jun 17, 2022
Updates in Vasomotor Symptom Treatment
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Nanette F. Santoro, MD Tune out the noise and get to the heart of managing menopause and associated vasomotor symptoms. This program provides highlights from the 2022 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting. Join Drs. Nanette Santoro and Lee Shulman as they dive into the latest research, which could alter your current practice patterns and help your patients cool off.
13 minutes | Jun 16, 2022
New Horizons in the Medical Management of Endometriosis: The Role of GnRH Antagonists: A “Voice of Patient/Voice of Provider” Curriculum
Host: Ayman Al-Hendy, MD Despite its profound impact, endometriosis remains critically undermanaged. This program provides highlights from a live symposium at the annual meeting for obstetrics and gynecology professionals and is based on patient & provider surveys. Join Dr. Ayman Al-Hendy to explore management gaps, the role of GnRH antagonists in addressing deficits, and the latest research, which he presented with Drs. Andrea Lukes and Lee Shulman—you might just alter your current practice patterns.
13 minutes | Apr 29, 2022
Focus on the New Menopause Management Horizon: Improving Outcomes Through Managed Care
Host: Jeffery D. Dunn, PharmD, MBA Guest: Gary M. Owens, MD Guest: Anita L. Nelson, MD Are you ready to see what is on the horizon to more effectively navigate vasomotor symptoms (VMS)? Join Drs. Dunn, Owens, and Nelson as they discuss highlights from a symposium held at AMCP 2022 featuring the latest data on the impact of menopause and evolving treatments options. They provide guidance, context, and recommendations for the medical management of VMS beyond estrogen. The nonhormonal treatment options that are currently being studied represent a new horizon for both patients and payers.
16 minutes | Mar 25, 2022
Strategies to Improve Patient Communication About the Vaginal pH Modulator
Host: Patty Cason, RN, MS, FNP-BC Guest: Joely Pritzker, RN, MS, FNP-C Are you ready to apply the latest counseling techniques to address the contraceptive revolution? Join nurse practitioners Patty Cason and Joely Pritzker as they briefly review the history of contraceptive counseling and then use case vignettes to illustrate how shared decision-making techniques will support the appropriate use of nonhormonal contraceptive options, such as the vaginal pH modulator (VPM). Participating in this activity will ensure that you are ready to effectively counsel patients on their many options so that each patient’s reproductive and sexual health goals can be met.
14 minutes | Feb 11, 2022
The Vaginal pH Modulator: A Revolutionary Approach to Contraception
Host: David J. Portman, MD Guest: Patty Cason, RN, MS, FNP-BC Guest: David L. Eisenberg, MD, MPH, FACOG A revolution is occurring in reproductive and sexual health as new contraceptive options emerge. Listen in as 3 distinguished experts—Dr. David Portman, Dr. David Eisenberg, and Ms. Patty Cason—discuss recent advances in contraception. They focus on how choices with novel mechanisms of action may empower patients and impact choice. As cutting-edge, nonhormonal options emerge, including the VPM, it is critical for clinicians to help patients select contraceptive options that meet their sexual and reproductive health goals. Do you know how to apply the latest information on contraceptive efficacy, the creeping Pearl Index, and sexual satisfaction when counseling patients in clinical practice? Are you doing all you can to ensure that your patients’ needs are optimally addressed? Tune in, because you can always learn more…
16 minutes | Jan 31, 2022
Misconceptions, Benefits, and Disadvantages of the Newer Oral GnRH Antagonists in the Management of Uterine Fibroids and Endometriosis
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Ayman Al-Hendy, MD Surgery has long been the default choice when managing uterine fibroids and endometriosis. However, over the past few years, reliable and durable medical interventions have emerged, notably GnRH antagonist therapy. Clinical trial data for GnRH antagonists highlight both their safety and efficacy for a broad demographic of patients. Join Drs. Lee Shulman and Ayman Al-Hendy as they discuss the “how” and the “why” of a paradigm shift that is occurring, changing our focus from surgery to first-line medical intervention for uterine fibroids and endometriosis.
13 minutes | Dec 21, 2021
Medical Management of Uterine Fibroids and Endometriosis: The Emerging Value Proposition Surrounding the New Oral GnRH Antagonists
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Andrea S. Lukes, MD, MHSc, FACOG By 50 years of age, 70% to 80% of women are affected by uterine fibroids, and nearly 10% of women are affected by endometriosis. Clinical trial data demonstrate that GnRH antagonist therapy can dramatically impact pain and bleeding and improve results across all EHP-30 domains. Join Drs. Lee Shulman and Andrea Lukes as they dive into these data and offer strategies to help you better incorporate patient-centric medical management for uterine fibroids and endometriosis into your clinical practice.
39 minutes | Dec 8, 2021
Addressing the Unique Needs of Women with Migraine
Guest: Peter Goadsby, MD, PhD, DSc Guest: Kathleen B. Mullin, MD Women with migraine have unique needs that often remain undermanaged. Have you taken a critical look at the standard of care and how current treatment strategies have recently shifted? Groundbreaking research on the calcitonin gene-related peptide (CGRP) pathway has led to the development of new medications that act on the specific cascade of inflammatory response associated with migraine. Also called gepants, the CGRP receptor antagonists confer clinical benefit to patients who seek better control of their migraines. Tune in to this Women’s Health 2021 program to hear our experts, Drs. Peter Goadsby and Kathleen Mullin, discuss the diagnosis of migraine with a focus on the recent evolution of acute and preventive treatment strategies and the role of gepants. Are you doing all you can to ensure that your patients’ needs are optimally addressed?
17 minutes | Nov 30, 2021
Factors That Delay Diagnosis of Uterine Fibroids and Endometriosis: The Demographic Divide
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Erica E. Marsh MD, MSCI, FACOG Hear from Dr. Erica Marsh and Dr. Lee Shulman as they discuss the burden, prevalence, and treatment of uterine fibroids and endometriosis and the disproportionate impact these conditions have on vulnerable populations. Learn how to prioritize early diagnosis and treatment to improve outcomes for your patients; as well as evaluating barriers to proper diagnosis and treatment Our experts offer strategies to guide discussions beyond surgical treatment approaches to include pharmacotherapeutic options such as GnRH agonists and new oral GnRH antagonists. Open communication with patients allows them to carefully consider symptom severity, risks, and fertility preferences to optimize treatment outcomes and patient satisfaction. Tune in to make sure that you’re really doing all you can for your patients.
43 minutes | Nov 30, 2021
Optimizing Medical Management of Uterine Fibroids: Achieving Patient-Centered Goals and Outcomes
Host: Anita L. Nelson, MD In this Women’s Health 2021 lecture, Dr. Anita Nelson discusses why uterine fibroids are such a high priority for both women and their clinicians. Listen in as she shares strategies to engage patients in discussions about their fibroid symptoms and their preferences for treatment. Dr. Nelson also evaluates the latest evidence on the mechanisms of action, safety, and efficacy of the newer class of therapies that are now available and can improve the quality of life for women with fibroids.
24 minutes | Nov 30, 2021
Advances in Postpartum Depression: What You Need to Know
Host: Anita H. Clayton, MD Listen in as Dr. Anita Clayton takes us through the importance of screening for postpartum depression (PPD) and reaching an early diagnosis in the perinatal and postnatal stages of pregnancy. This Women’s Health 2021 lecture also covers the exciting new agents that are targeted specifically for PPD. Find out how they compare to the traditional antidepressants and how they can improve the quality of life for your patients with PPD.
45 minutes | Nov 30, 2021
Individualizing Management of Endometriosis Pain: Current Evidence, Potential New Strategies, and Ongoing Research
Host: Anita L. Nelson, MD How confident are you in determining which of your patients with endometriosis are suitable candidates for medical intervention? Do you ask about each patient’s goals and preferences? Have you heard about the paradigm shift occurring in the medical management of endometriosis? While medical management of endometriosis is often a secondary consideration to surgery, it should often be the first line of treatment. Join Dr. Anita Nelson as she discusses long-standing and novel medical strategies for managing endometriosis. Find out how you can use shared decision-making strategies to help you provide more options to your patients. Join us and take an important first step that can improve outcomes and quality of life for your patients while enabling them to make educated decisions about their immediate and long-term treatment.
22 minutes | Oct 29, 2021
Osteoporosis: The Pivotal Role That Orthopedic Surgeons Can Play in Optimizing the Bone Health of Their Postmenopausal Post-Fracture Patients
Host: Andrea Singer, MD, FACP, CCD Guest: Paul A. Anderson, MD Guest: Susan V. Bukata, MD, FAOA, FAAOS While there’s growing awareness among orthopedic surgeons that osteoporosis is the underlying cause of fractures, there is often a disconnect between this recognition and action in the form of treatment to prevent subsequent fractures. In this discussion, Drs. Andrea Singer, Paul Anderson, and Susan Bukata address the pathophysiology of osteoporosis and the need to identify patients at risk for additional fractures. Osteoporosis treatment (including pharmacotherapy) can play a critical role in preventing future fractures, but physicians must first recognize that fracture is a sentinel event and treat it as a call to action.
30 minutes | Sep 30, 2021
Expanding Contraceptive Choices for Women: The Vaginal pH Modulator
Host: David L. Eisenberg, MD, MPH, FACOG Many women prefer to use a nonhormonal contraceptive. They also want the freedom to self-administer on demand and want assurances that the contraceptive is safe, effective, and has received FDA approval. One such contraceptive is a self-administered, hormone-free gel that functions as a vaginal pH modulator. Join Dr. David Eisenberg as he describes the evolution of this vaginal pH modulator and the clinical trials leading to FDA approval. Even more significant is patient acceptance, which was remarkably high for this contraceptive. In fact, approximately 9 out of 10 women participating in the clinical trials indicated they would continue using the vaginal pH modulator and also recommend this novel method to their friends.
27 minutes | Sep 30, 2021
Shining a New Light on the Contraceptive Patch
Host: Brooke M. Faught, DNP, WHNP-BC,NCMP, IF Our patients express a number of misperceptions about combined hormonal non-LARC contraceptives such as the contraceptive patch, vaginal rings, and oral contraceptive pills. How well do you explain the advantages and disadvantages of these different options to your patients? How often have you prescribed what appeared to be a good contraceptive method for your patients only to have them be dissatisfied and become nonadherent? Join Dr. Brooke Faught in this Women’s Health 2021 lecture as she tackles these issues and offers insights into how to discuss the full range of combined hormonal non-LARC contraceptive options with your patients using shared decision-making strategies. Remember, each patient’s needs, goals, and cultural background are important factors in a patient-centric approach to the choice of contraception.
43 minutes | Sep 30, 2021
A Closer Look at Women, Atherosclerosis, and Lipids: What Is Different?
Guest: Gregory Pokrywka MD, FACP, FNLA, FASPC, NCMP Guest: Karol Watson, MD, PhD Join us to discover optimal ways to identify women at risk or with atherosclerotic cardiovascular disease (ASCVD). In this Women’s Health 2021 lecture, our experts, Dr. Gregory Pokrywka and Dr. Karol Watson, dive deeper into evidence-based approaches to assess and manage ASCVD in women. They discuss topics from lifestyle modifications to recent clinical trial data on the use of omega-3 fatty acids for ASCVD event reduction.
16 minutes | Aug 27, 2021
Counseling Your Patients At Risk of HDFN
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Michelle Y. Owens, MD OB-GYN clinicians can improve how they communicate with their patients about hemolytic disease of the fetus and newborn or HDFN. Strategies include encouraging patients to talk about their feelings when learning about this condition and communicating with them in terms that are not overly complex. In this program, Drs. Lee Shulman and Michelle Owens discuss how to break things down for the patient in front of you and explain how to use a read-back approach. This tactic ensures that your patient has absorbed what was discussed and also allows you to identify gaps in her understanding that can be addressed with further counseling.
13 minutes | Aug 11, 2021
Optimizing Breastfeeding Within the Golden Hour
Host: Hector O. Chapa, MD, FACOG Guest: Susan Crowe, MD Both UNICEF and WHO recommend exclusive breastfeeding for the first six months of life, starting within the very first hour of birth. But are we adhering to that recommendation? Joining Dr. Hector Chapa to discuss the importance of breastfeeding shortly after delivery and how we can help our patients and their newborns reap the benefits of this golden hour is Dr. Susan Crowe, Director of Outpatient Breastfeeding Medicine Consultative Services at Stanford Children's Health who recently spoke about this topic at the 2021 ACOG Annual Clinical and Scientific Meeting.
17 minutes | Jul 28, 2021
HDFN: New Understandings of Risk, Diagnosis, and Therapeutic Approaches
Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Kenneth J. Moise, Jr., MD Guest: Christopher Robinson, MD Hemolytic disease of the fetus and newborn (HDFN) is a rare disease that occurs due to the incompatibility between fetal and maternal red cell antigens. HDFN can lead to both short- and long-term consequences, including potentially fatal outcomes. In order to better prevent these associated issues, the timely evaluation, recognition, and treatment of HDFN are critical. Listen in as three leading experts, Drs. Lee Shulman, Kenneth Moise, and Christopher Robinson, join together to discuss new epidemiologic evidence, the underlying pathophysiology of HDFN, health equity, and evolving management strategies you can implement to improve your clinical practice.
13 minutes | Jul 15, 2021
Choosing OB-GYN: One Practitioner’s Story
Host: Ana Maria Rosario Guest: Patricia M. Boatwright, MD As any healthcare professional would agree, being passionate about your practice is key to having a good relationship with your patients. But choosing a specific specialty isn’t always an easy or clear decision. Joining Ana Maria Rosario to share how she came to her decision and a few experiences that made her into the healthcare professional she is today is Dr. Patricia Boatwright, an ob-gyn and Associate Professor of Surgery and Population Health Sciences at Duke University School of Medicine.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2022